Form D · Pharmaceuticals
ELUTE, INC.
Salt Lake City, UT · CIK 0001670751
Offering snapshot reported Mar 31, 2016 · SEC filing
- Reported sold
- $1.64M Offering amount: $4.8M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2016 | Initial | $1,635,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $118K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-260385
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Westlake Securities | 127112 |
Source: Form D, filed Mar 31, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kirk P. Andriano | Director, Executive |
| Cheryl R. Blanchard | Director |
| Philip A. Davidson | Director |
| Dennis B. Farrar | Director, Executive |
| David W. Grainger | Director, Executive |
| Ashok C. Khandkar | Director, Executive |
| Daniel P. Liston | Executive |
| Kristofer D. Sinclair | Executive |
| Stephanie L. Sorensen | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
417 Wakara Way Suite 3510
Salt Lake City, UT, 84108
Salt Lake City, UT, 84108